Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Dexmedetomidine in Rhinoplasty
NCT05572723Phase 4Completed
- Sponsor
- Baskent University
- Start
- Mar 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, sponsored by Baskent University. Primary endpoints: Mean Arterial Pressure and Postoperative Pain at 30 months. Started Mar 2022; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT05572723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05572723.